Gastric Cancer

• CLINICAL_TRIALS trial_result · 2022-05-26
  Clinical Trial Update: Neoadjuvant TACiE in Locally Advanced Gastric Cancer [Phase 2]

  A Phase 2 clinical trial update for neoadjuvant TACiE in locally advanced gastric cancer; current status is unknown.

• CLINICAL_TRIALS trial_result · 2022-05-24
  Clinical Trial Update: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer [Phase 2]

  Phase 2 trial updating bemarituzumab with modified FOLFOX6 in gastric/gastroesophageal junction cancer has completed with results posted in …

• CLINICAL_TRIALS trial_result · 2022-05-24
  Clinical Trial Update: Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) [Phase 2]

  Phase 2 trial update investigating transarterial chemoembolization with Lipiodol for initial unresectable gastric cancer.

• CLINICAL_TRIALS trial_result · 2022-05-18
  Clinical Trial Update: Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma [Phase 2]

  Phase 2 trial evaluating ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in HER2-positive gastroesophageal adenocarcinoma…

• CLINICAL_TRIALS trial_result · 2022-05-09
  Clinical Trial Update: An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers [Phase 2]

  A Phase 2 study evaluating immunotherapy in combination with chemotherapy for gastric cancer and gastroesophageal junction cancers; the tria…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-05-05
  Clinical Trial Update: Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma [Phase 2]

  Phase 2 trial evaluating adjuvant XELOX chemotherapy with concurrent capecitabine and radiotherapy for resected gastric cancer completed.

• CLINICAL_TRIALS trial_result · 2022-05-02
  Clinical Trial Update: HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer [Phase 2]

  Phase 2 trial update of HLX07+HLX10 with chemotherapy or HLX07 monotherapy in advanced/metastatic gastric/gastroesophageal junction cancer i…

• CLINICAL_TRIALS trial_result · 2022-05-02
  Clinical Trial Update: Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

  Phase 1/2 trial update evaluating NKT cell infusion for advanced solid tumors, with indications including non-small cell lung cancer and gas…

• CLINICAL_TRIALS trial_result · 2022-04-11
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer [Phase 2]

  Phase 2 trial evaluating sintilimab plus apatinib and chemotherapy for HER-2 negative MSS advanced or metastatic gastric or gastroesophageal…

• CLINICAL_TRIALS trial_result · 2022-04-06
  Clinical Trial Update: RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer [Phase 2]

  Phase 2 trial update involving RC48 plus AK105 and cisplatin in advanced gastric cancer, including HER2-positive cases.

• CLINICAL_TRIALS trial_result · 2022-04-05
  Clinical Trial Update: Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer [Phase 2]

  Phase 2 trial update investigating HLX10 with trastuzumab and chemotherapy as first-line treatment for HER2-positive recurrent/metastatic ga…

• CLINICAL_TRIALS trial_result · 2022-04-01
  Clinical Trial Update: Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer [Phase 3]

  Phase 3 trial comparing palliative surgery after translational therapy to maintenance chemotherapy in metastatic gastric cancer; status not …

• CLINICAL_TRIALS trial_result · 2022-03-15
  Clinical Trial Update: Apatinib for the Elderly Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update evaluating apatinib in elderly patients with advanced gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2022-03-11
  Clinical Trial Update: Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer [Phase 2]

  Phase 2 trial evaluating toripalimab with chemotherapy as neoadjuvant treatment for gastric cancer is ongoing with unknown status.

• CLINICAL_TRIALS trial_result · 2022-03-11
  Clinical Trial Update: Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]

  Phase 2 trial evaluating Sintilimab plus nab-paclitaxel as second-line therapy for advanced gastric and gastro-esophageal junction adenocarc…

• CLINICAL_TRIALS trial_result · 2022-03-11
  Clinical Trial Update: Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer [Phase 2]

  Phase 2 trial update evaluating pembrolizumab plus ramucirumab in metastatic gastric cancer.

• CLINICAL_TRIALS trial_result · 2022-03-08
  Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial [Phase 2]

  Phase 2 trial updating safety and efficacy of Tislelizumab with Zanidatamab as second-line therapy in HER2-positive advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2022-02-23
  Clinical Trial Update: A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer. [Phase 2]

  Phase 2 clinical trial update for MRG002 in HER2-positive/HER2-low locally advanced or metastatic gastric/gastroesophageal junction cancer.

• CLINICAL_TRIALS trial_result · 2022-02-21
  Clinical Trial Update: Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]

  Phase 2 comparative study evaluating lobaplatin versus paclitaxel in advanced gastric cancer patients who underwent D2 gastrectomy with hype…

• CLINICAL_TRIALS trial_result · 2022-02-21
  Clinical Trial Update: Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) [Phase 3]

  Phase 3 trial assessing the optimal duration of oxaliplatin in adjuvant XELOX for gastric cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2022-02-17
  Clinical Trial Update: A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]

  Phase 2 trial of ipatasertib with fluoropyrimidine plus oxaliplatin in advanced/metastatic gastric or gastroesophageal junction cancer compl…

• CLINICAL_TRIALS trial_result · 2022-02-17
  Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

  Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…

• CLINICAL_TRIALS trial_result · 2022-02-16
  Clinical Trial Update: A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer [Phase 2]

  A Phase II clinical trial evaluating Fruquintinib combined with RC48 for previously treated HER2-positive locally advanced or metastatic gas…

• CLINICAL_TRIALS trial_result · 2022-02-15
  Clinical Trial Update: Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) [Phase 2, Phase 3]

  A Phase 2/3 trial update evaluating varlitinib in combination with mFOLFOX6 as first-line therapy for advanced or metastatic gastric cancer …

• CLINICAL_TRIALS trial_result · 2022-02-14
  Clinical Trial Update: Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer [Phase 2]

  Phase II study comparing dendritic cell (DC) therapy versus 5-FU/CF as chemotherapy and concurrent chemoradiotherapy for locally advanced ga…